The Global Hernia Mesh Repair Devices Market is poised to reach USD 4.5 billion by 2024, from USD 3.8 billion in 2016 growing at a CAGR of 2.1% in the forecast period 2017 to 2024.
An Estimated around 11.2 million hernia repair surgeries were performed globally in 2015 and this number is projected to reach approximately 12.6 million by 2024, growing at the rate of 1.7% during the Forecasted years 2017 to 2024. The report includes inguinal, umbilical, femoral, incisional and other kinds of hernia such as hiatal hernia. Inguinal hernia is proven to be the most common form of hernia and constituted around 56.1% of the total number of hernia surgeries performed in the year 2015, followed by incisional or ventral hernia surgeries with 16.3%. Femoral hernia occurring are very rare and only forms 1.5% of all hernia surgeries in 2015. Hernia surgeries require closing or sealing the weak spot present in the muscle through which intestinal content is protruding out. Presently, there are two treatment options available – hernia repair surgeries using sutures and hernia repair using mesh.
The global hernia mesh repair devices market report scope includes market value (USD Million), market Volume (units), average selling price (USD) and procedure volume from 2017 to 2024.
The global hernia mesh market is segmented into 2 mesh types based on material into synthetic mesh and biologic mesh. The report further classifies Synthetic mesh into flat mesh and 3D mesh on the basis of structure of the mesh and into absorbable and non-absorbable based on the material the synthetic mesh is made of. Flat mesh is the most used mesh and accounts to more than 70% of the synthetic mesh segment in terms of market value. The market share of usage of absorbable and non-absorbable synthetic meshes is varying from country to country based on the surgeon’s perspective in different countries. Synthetic mesh is expected to dominate the market with 63.7% market share in 2016, owing to its affordability and incredible clinical acceptance from surgeons and the government. Biologic mesh is quite new to the market, and is able to capture 6.2% of the market, in terms of volume in 2015, owing to its clinical effectiveness and very less recurrence rates. The U.S. is the only country using biologic meshes very efficiently due the reimbursements being good and affordability not being an issue. The U.S. holds almost 58.0% of the biologic mesh market in terms of value in 2015.
On the basis of hernia types the market is segmented into inguinal hernia, femoral hernia, incisional hernia, umbilical hernia and other hernia types. In 2016, incisional hernia is expected to dominate the market owing to its often occurrence and severity of pain.
Based on geography the global hernia mesh repair devices market covers data points for 52 countries across multiple geographies namely North & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others. The North America dominates the market in terms of consumption of hernia repair mesh followed by Europe and APAC. In terms of revenue North America holds 46.3% of the market in 2015, followed by Europe with 32.6% and APAC with 23.6%. APAC is expected to be the fastest growing market in the forecasted years due to huge number of hernia surgeries in India and China are still being operated using sutures and that scenario is expected to change due to better healthcare infrastructure and increasing awareness of minimally invasive surgeries in this region.
The report scope includes hernia mesh repair devices market competitive landscape for all major countries. Market shares are provided to manufacturers based on market trends and futuristic approaches and strategies used by them is also explained in the report. The company profiles segment also includes pipeline analysis, SWOT analysis, mergers and acquisitions, new product launch and other recent developments. Some of the major players operating in this market are Ethicon, Inc., Medtronic, C.R. Bard, Inc., Atrium, W.L. Gore & Associates, Acelity and B Braun Melsungen AG among other players.